Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

British journal of haematology·2026
Same author

Plain language summary of publication of how long people with relapsed multiple myeloma lived after treatment in the IKEMA study: Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone.

Future oncology (London, England)·2026
Same author

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

Blood research·2026
Same author

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

The New England journal of medicine·2026
Same author

Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal Function.

Clinical lymphoma, myeloma & leukemia·2026

Related Experiment Video

Updated: Jan 12, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.2K

Risk Stratification Strategies and Implementation of Exercise Training in Patients with Multiple Myeloma.

Sung-Soo Park1, Eui-Soon Kim2, Jong-Chan Youn3

  • 1Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Current Oncology Reports
|November 3, 2025
PubMed
Summary

Exercise is crucial for multiple myeloma (MM) patients, but safe and effective regimens require personalized approaches. Further research is needed to understand long-term benefits for disease progression and survival.

Keywords:
Exercise trainingMultiple myelomaRisk stratification

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K

Related Experiment Videos

Last Updated: Jan 12, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K

Area of Science:

  • Hematology
  • Oncology
  • Exercise Physiology

Background:

  • Multiple myeloma (MM) presents complex complications affecting patient health and quality of life.
  • Exercise training is vital supportive care, but MM's complexities challenge safe and effective intervention design.

Purpose of the Study:

  • To review clinical considerations for exercise prescription in multiple myeloma (MM).
  • To evaluate evidence for safe and effective exercise regimens in MM patients.

Main Methods:

  • Literature review of current evidence on exercise interventions for MM.
  • Analysis of tools for personalizing exercise prescriptions (e.g., cardiopulmonary exercise testing, fracture risk assessment, biomarker monitoring).

Main Results:

  • Aerobic and resistance training show potential benefits, but optimal protocols lack consensus.
  • Personalization tools show promise, but long-term effects on MM progression, survival, and quality of life remain under-researched.
  • Feasibility and short-term benefits of exercise in MM are established.

Conclusions:

  • Evidence supports exercise for MM, but significant knowledge gaps exist regarding long-term outcomes.
  • Future research should focus on refining evidence-based guidelines for exercise in MM.
  • Personalized exercise prescriptions are key for safety and efficacy in MM patients.